Crossmark

Time-variant tumor growth trajectory models for in silico randomized controlled trials for patients with early-stage non-small cell lung cancer in optimizing stereotactic body radiation therapy

Crossref DOI link: https://doi.org/10.1007/s12553-025-01005-2

Published Online: 2025-08-05

Published Print: 2025-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mitsushima, Kazuki https://orcid.org/0009-0001-1282-0204
Arimura, Hidetaka

Shirakawa, Yuko

Kodama, Takumi

Yoshitake, Tadamasa
Funding

Funding for this research was provided by:

Japan Society for the Promotion of Science (JP23KJ1733, JP24K10840)
License Information

Text and Data Mining valid from 2025-08-05

Version of Record valid from 2025-08-05
More Information

Article History

Received: 8 January 2025

Accepted: 8 July 2025

First Online: 5 August 2025

Declarations

:

: This retrospective study was performed with ethical approval from the Institutional Review Boards of Kyushu University Hospital (approval number:22307–00).

: Given the retrospective study design, informed consent was obtained through an opt-out procedure, whereby patients were provided with the clear information and the opportunity to withdraw their data from the study.

: Given the retrospective study design, informed consent was obtained through an opt-out procedure, whereby patients were provided with the clear information and the opportunity to withdraw their data from the study.

: Not applicable.

Document is current

Any future updates will be listed below